GeoVista key facts
- Developer of pet therapeutics designed to address chronic and age-related diseases in animals.
- It has raised $2.0M; the latest was Later Stage VC in Jan 2027.
- Notable investors include Tech Incubator Program for Startup, Korea Credit Guarantee Fund, IBK Venture Investment, GTO Investment, iAccel (Seongnam-si).
- Status: Privately Held (backing).
- ·Watch GeoVista: the Monday email on marks, rounds and moves
GeoVista funding rounds
No funding rounds for GeoVista are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
GeoVista investors
5 investors are on record for GeoVista, including Tech Incubator Program for Startup, Korea Credit Guarantee Fund, IBK Venture Investment and GTO Investment.
About GeoVista
Developer of pet therapeutics designed to address chronic and age-related diseases in animals. The company offers treatments for atopic dermatitis, osteoarthritis, and separation anxiety, enabling pet owners to treat their pets.
- Sector
- Healthcare
- HQ
- Yongin, South Korea
- Founded
- 2020
- Employees
- 5
- Website
- geovista.org/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
GeoVista doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.